MyMD Pharmaceuticals, Inc.

NASDAQ:MYMD

1.81 (USD) • At close July 23, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q1
Revenue 0000000000000000.29100.080.4210.4650.6120.2790.5570.5270.3021.3890.6761.1980.6670.6530.6130.9560.7380.4690.1690.9670.511.4470.4531.3531.17400.3451.0761.585
Cost of Revenue 0000000000000000.37700.3470.2860.220.2460.4620.4760.3030.2980.5730.3240.2640.2590.370.2370.2770.20.2050.1780.3410.2260.2670.1620.1410.6044.510.0940.6330.776
Gross Profit 000000000000000-0.0860-0.2670.1350.2450.366-0.1820.0810.2240.0050.8150.3520.9340.4090.2840.3760.680.5380.263-0.0080.6260.2841.1790.2911.2120.57-4.510.2510.4430.809
Gross Profit Ratio 000000000000000-0.2940-3.360.3220.5270.598-0.6520.1450.4250.0160.5870.5210.7790.6120.4340.6140.7110.7290.562-0.050.6470.5560.8150.6420.8950.4851.50.7270.4120.51
Reseach & Development Expenses 1.1992.9611.9122.2240.772.471.8032.1642.631.3082.7681.49-0.0191.0310.9081.9162.4830.070.0580.0610.0880.2030.1610.2590.440.3080.290.3140.3480.2560.2480.3220.3630.4030.320.3780.3060.230.1840.2490.2540.7560.2340.2740.248
General & Administrative Expenses 1.5861.9481.933.5571.0571.3381.9071.4791.4921.8181.64116.7481.5083.6031.0320.8041.0550.8690.8950.9810.9831.4781.7071.5660.9161.6420.820.830.7910.7110.5580.8160.9240.8240.761.7470.6981.4820.8271.0170.6541.0460.3710.3810.295
Selling & Marketing Expenses 0000000000000000.0070.0060.0360.0380.0140.150.4480.3650.4690.50.6660.3770.4160.5890.3720.5260.5130.7250.6890.7260.5540.5750.3360.3590.3970.211-0.5370.1270.1760.234
SG&A 1.5861.9481.933.5571.0571.3381.9071.4791.4921.8181.64116.7481.5083.6031.0320.8121.0610.9050.9330.9951.1331.9262.0712.0351.4162.3081.1971.2461.3791.0831.0841.331.6491.5131.4862.31.2741.8171.1851.4140.8651.5830.4970.5570.529
Other Expenses 0-0.763000.7630.6950000000000.00900.010.010.010.010.0430.0430.0430.0430.0430.0430.0430.0430.0430.0430.0430.0430.0430.0650.0650.0650.0650.0650.0650.065-0.1940.0650.0650.065
Operating Expenses 2.7854.9093.8435.7822.593.8083.713.6434.1223.1264.40818.2381.4894.6391.9452.7373.5440.9851.0011.0661.2312.1722.2752.3371.8982.6591.531.6031.7711.3821.3751.6942.0551.9591.872.7431.6442.1121.4341.7271.1832.3390.7960.8960.841
Operating Income -2.785-4.909-3.843-5.782-2.59-3.808-3.71-3.643-4.122-3.034-4.408-18.278-1.489-4.169-3.242-3.116-3.544-1.252-0.865-0.822-0.865-2.354-2.194-2.113-1.893-1.844-1.178-0.669-1.362-1.098-0.998-1.015-1.517-1.696-1.879-2.117-1.36-0.932-1.143-0.516-0.6131.03-0.545-0.453-0.032
Operating Income Ratio 000000000000000-10.690-15.737-2.057-1.769-1.413-8.427-3.939-4.013-6.26-1.328-1.742-0.559-2.041-1.681-1.628-1.061-2.055-3.619-11.087-2.189-2.667-0.645-2.521-0.381-0.522-0.343-1.582-0.421-0.02
Total Other Income Expenses Net -7.0152.5457.7471.4391.0790.0630.0160.001-0-0.208-1.0610.18-0.00200-0.513-0.037-0.0870.0280.027-0.052-1.483-0.890.0460.033-0.768-00.0030.0130.0021.3090.0060.008-2.15-0.4480.0310.0380.020.0180.0210.018-0.2850.0010.1920.092
Income Before Tax -9.8-2.3644.043-4.168-1.512-3.746-3.694-3.636-4.122-3.24-5.467-18.092-1.447-4.169-3.242-3.628-3.534-1.339-0.837-0.795-0.917-3.838-3.084-2.067-1.86-2.612-1.178-0.667-1.349-1.0960.31-1.009-1.509-3.846-2.327-2.086-1.322-0.912-1.124-0.495-0.5960.745-0.544-0.2610.06
Income Before Tax Ratio 000000000000000-12.4490-16.829-1.989-1.711-1.498-13.735-5.536-3.926-6.149-1.881-1.743-0.557-2.022-1.6780.506-1.055-2.045-8.208-13.73-2.158-2.592-0.631-2.48-0.366-0.507-0.248-1.579-0.2430.038
Income Tax Expense 1.202-0.0051.158-0.175-1.079-0.063-0.032-0.006-0-0.002-0.002-0.006-0.008-0.471.297-0.513-0.043-0.0870.0280.027-0.052-1.483-0.890.0460.033-0.7680.0030.0030.0130.0021.3120.0060.008-0.269-0.4480.0310.0380.020.0180.0160.02800.0010.1920.093
Net Income -9.8-2.3644.043-4.168-0.433-3.683-3.662-3.636-4.122-3.24-5.467-18.092-1.483-4.169-3.242-3.628-3.539-1.339-0.837-0.795-0.917-3.838-3.084-2.067-1.86-2.612-1.178-0.667-1.349-1.0960.31-1.009-1.509-3.577-2.327-2.086-1.322-0.912-1.124-0.495-0.5960.745-0.544-0.2610.06
Net Income Ratio 000000000000000-12.4490-16.829-1.989-1.711-1.498-13.735-5.536-3.926-6.149-1.881-1.743-0.557-2.022-1.6780.506-1.055-2.045-7.633-13.73-2.158-2.592-0.631-2.48-0.366-0.507-0.248-1.579-0.2430.038
EPS -4.58-1.422.7-3.1-0.33-2.8-0.094-0.095-0.11-0.086-0.15-0.5-0.04-0.11-0.087-0.69-0.095-0.6-1.61-1.53-1.76-7.38-6.28-4.26-5.01-7.03-25.43-14.41-37.04-30.0810.96-35.69-53.4-126.6-86.84-77.86-49.51-34.17-43.83-19.42-27.2484.48-58.33-36.649.06
EPS Diluted -4.58-1.422.7-3.1-0.33-2.8-0.094-0.095-0.11-0.086-0.15-0.5-0.04-0.11-0.087-0.69-0.095-0.6-1.61-1.53-1.76-7.38-6.28-4.26-5.01-7.03-25.43-14.41-37.04-30.0810.81-35.69-53.4-126.6-86.84-77.86-49.51-34.17-43.83-19.42-27.2484.48-58.33-36.649.06
EBITDA -2.785-4.909-11.59-7.221-3.643-3.741-3.696-3.639-4.122-3.082-4.407-18.232-1.487-4.634-1.94-3.616-3.508-1.32-0.817-0.775-0.902-3.776-3.024-2.011-1.804-2.545-1.113-0.606-1.289-1.0320.422-0.952-1.452-3.788-2.246-2.006-1.241-0.824-1.036-0.408-0.4980.764-0.558-0.070.15
EBITDA Ratio 000000000000000-12.4080-16.584-1.943-1.669-1.473-13.515-5.428-3.819-5.963-1.833-1.647-0.506-1.931-1.5790.689-0.995-1.968-8.083-13.255-2.074-2.434-0.57-2.286-0.302-0.424-0.254-1.618-0.0650.094